Dodge & Cox Organon & Co. Transaction History

Dodge & Cox

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $185,337 - $227,720	-5,854 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $90,101 - $116,466	-2,959 Reduced 33.58%	5,854 $204,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $255,163 - $330,457	-8,900 Reduced 50.25%	8,813 $268,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $142,720 - $177,665	-4,985 Reduced 21.96%	17,713 $581,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $645,758 - $862,524	22,698 New	22,698 $686,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

Stay updated on Dodge & Cox with notifications on news.